Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-004249)

Filing Details

Accession Number:: 0001415889-25-004249
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-14 18:13:50
Reporting Period:: 2025-02-14

Filing Date:: 2025-02-14
Accepted Time:: 2025-02-14 18:13:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1211583	Fennec Pharmaceuticals Inc.	FENC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1185945	A Chris Rallis	C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2025-02-14	1,992	$2.51	54,206	No	4	M	Direct
Common Shares	Disposition	2025-02-14	1,186	$6.82	53,020	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Options	Common Shares	Disposition	2025-02-14	1,992	$2.51	1,992	$2.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
182,706	2015-03-16	2025-03-16	No	4	M	Direct

Footnotes

Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
Shares sold to satisfy tax obligation on option exercise.
Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.